SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203228781> ?p ?o ?g. }

Showing items 1 to 100 of ±275 with 100 items per page.

W3203228781 endingPage "936" @default.
W3203228781 startingPage "927" @default.
W3203228781 abstract "An enhanced surveillance schedule has been proposed for cirrhotics with viral etiology, who are considered at extremely high-risk of hepatocellular carcinoma (HCC).We compared the 3- and 6-months surveillance interval, evaluating cancer stage at diagnosis and patient survival.Data of 777 HBV and HCV cirrhotic patients with HCC diagnosed under a 3-months (n = 109, 3MS group) or a 6-months (n = 668, 6MS group) surveillance were retrieved from the Italian Liver Cancer database. Survival in the 3MS group was considered as observed and adjusted for lead-time bias, and survival analysis was repeated after a propensity score matching.The 3-months surveillance interval neither reduced the share of patients diagnosed outside the Milano criteria, nor increased their probability to receive curative treatments. The median survival of 6MS patients (55.0 months [45.9-64.0]) was not significantly different from the observed (47.0 months [35.0-58.9]; p = 0.43) and adjusted (44.9 months [33.4-56.4]; p = 0.30) survival of 3MS patients. A propensity score analysis confirmed the absence of a survival advantage for 3MS patients.A tightening of surveillance schedule does not increase the diagnosis of early-stage tumors, the feasibility of curative treatments and the survival. Therefore, we should maintain the 6-months interval in the surveillance of viral cirrhotics." @default.
W3203228781 created "2021-10-11" @default.
W3203228781 creator A5000973050 @default.
W3203228781 creator A5001098190 @default.
W3203228781 creator A5001445594 @default.
W3203228781 creator A5002609899 @default.
W3203228781 creator A5003444448 @default.
W3203228781 creator A5003571894 @default.
W3203228781 creator A5004703306 @default.
W3203228781 creator A5006298484 @default.
W3203228781 creator A5006309755 @default.
W3203228781 creator A5009294046 @default.
W3203228781 creator A5010071655 @default.
W3203228781 creator A5010487468 @default.
W3203228781 creator A5010816829 @default.
W3203228781 creator A5011492082 @default.
W3203228781 creator A5012146178 @default.
W3203228781 creator A5013334772 @default.
W3203228781 creator A5014172694 @default.
W3203228781 creator A5014738272 @default.
W3203228781 creator A5015715160 @default.
W3203228781 creator A5017534922 @default.
W3203228781 creator A5018377091 @default.
W3203228781 creator A5019699020 @default.
W3203228781 creator A5020323314 @default.
W3203228781 creator A5020876233 @default.
W3203228781 creator A5025865489 @default.
W3203228781 creator A5027065335 @default.
W3203228781 creator A5027631947 @default.
W3203228781 creator A5028382814 @default.
W3203228781 creator A5029721718 @default.
W3203228781 creator A5030549960 @default.
W3203228781 creator A5030568271 @default.
W3203228781 creator A5030619209 @default.
W3203228781 creator A5032593836 @default.
W3203228781 creator A5032942040 @default.
W3203228781 creator A5033229461 @default.
W3203228781 creator A5033757788 @default.
W3203228781 creator A5035805538 @default.
W3203228781 creator A5036480997 @default.
W3203228781 creator A5038518740 @default.
W3203228781 creator A5038697021 @default.
W3203228781 creator A5039554062 @default.
W3203228781 creator A5039986171 @default.
W3203228781 creator A5040727807 @default.
W3203228781 creator A5041639329 @default.
W3203228781 creator A5042688675 @default.
W3203228781 creator A5043416750 @default.
W3203228781 creator A5045406649 @default.
W3203228781 creator A5046736321 @default.
W3203228781 creator A5047312459 @default.
W3203228781 creator A5048609769 @default.
W3203228781 creator A5050694729 @default.
W3203228781 creator A5050786916 @default.
W3203228781 creator A5051870259 @default.
W3203228781 creator A5053878589 @default.
W3203228781 creator A5056403286 @default.
W3203228781 creator A5056514950 @default.
W3203228781 creator A5056581003 @default.
W3203228781 creator A5057503092 @default.
W3203228781 creator A5059945290 @default.
W3203228781 creator A5060742428 @default.
W3203228781 creator A5062432231 @default.
W3203228781 creator A5063728960 @default.
W3203228781 creator A5064787053 @default.
W3203228781 creator A5065572516 @default.
W3203228781 creator A5066066943 @default.
W3203228781 creator A5068851875 @default.
W3203228781 creator A5069315930 @default.
W3203228781 creator A5071480411 @default.
W3203228781 creator A5073186349 @default.
W3203228781 creator A5073493755 @default.
W3203228781 creator A5073783997 @default.
W3203228781 creator A5074702669 @default.
W3203228781 creator A5074723888 @default.
W3203228781 creator A5075952854 @default.
W3203228781 creator A5076657757 @default.
W3203228781 creator A5077418457 @default.
W3203228781 creator A5078126497 @default.
W3203228781 creator A5079407869 @default.
W3203228781 creator A5079429440 @default.
W3203228781 creator A5079697307 @default.
W3203228781 creator A5081828621 @default.
W3203228781 creator A5081994892 @default.
W3203228781 creator A5082145853 @default.
W3203228781 creator A5084769321 @default.
W3203228781 creator A5085511371 @default.
W3203228781 creator A5086787753 @default.
W3203228781 creator A5087989451 @default.
W3203228781 creator A5090557088 @default.
W3203228781 creator A5091648269 @default.
W3203228781 creator A5036816004 @default.
W3203228781 date "2022-07-01" @default.
W3203228781 modified "2023-10-18" @default.
W3203228781 title "Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival" @default.
W3203228781 cites W1963747703 @default.
W3203228781 cites W1976467628 @default.
W3203228781 cites W1995300291 @default.